Braxia Scientific Corp. (BRAXF)
USD 0.0
(21.43%)
USD 0.0
(21.43%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.14 Million CAD | -8.3% |
| 2022 | -12.13 Million CAD | 86.34% |
| 2021 | -88.82 Million CAD | -51328.09% |
| 2020 | -172.72 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -802.25 Thousand CAD | 89.52% |
| 2024 Q3 | -907.04 Thousand CAD | -232.46% |
| 2024 Q2 | -272.83 Thousand CAD | 65.99% |
| 2023 Q1 | -968.84 Thousand CAD | 85.77% |
| 2023 FY | -13.14 Million CAD | -8.3% |
| 2023 Q4 | -7.65 Million CAD | -252.77% |
| 2023 Q3 | -2.17 Million CAD | 7.39% |
| 2023 Q2 | -2.34 Million CAD | -141.94% |
| 2022 FY | -12.13 Million CAD | 86.34% |
| 2022 Q2 | -1.7 Million CAD | -56.65% |
| 2022 Q1 | -1.09 Million CAD | 57.93% |
| 2022 Q3 | -2.52 Million CAD | -47.51% |
| 2022 Q4 | -6.81 Million CAD | -169.99% |
| 2021 FY | -88.82 Million CAD | -51328.09% |
| 2021 Q2 | -2.05 Million CAD | 97.52% |
| 2021 Q1 | -82.76 Million CAD | -2882.5% |
| 2021 Q3 | -1.54 Million CAD | 24.88% |
| 2021 Q4 | -2.59 Million CAD | -68.28% |
| 2020 Q4 | -2.77 Million CAD | -1768.84% |
| 2020 FY | -172.72 Thousand CAD | 0.0% |
| 2020 Q3 | -148.48 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bioxytran, Inc. | -4.28 Million USD | -207.049% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 82.469% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -4706.733% |
| SQZ Biotechnologies Company | -79.46 Million USD | 83.462% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -354.354% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 124.805% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 120.177% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -621.862% |
| Marizyme, Inc. | -65.34 Million USD | 79.889% |
| Genus plc | 7.9 Million USD | 266.351% |
| Pharming Group N.V. | -10.54 Million USD | -24.59% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -505.66% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -254.201% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -48.595% |
| ContraFect Corporation | -65.15 Million USD | 79.829% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -660.755% |
| IMV Inc. | -36.48 Million USD | 63.981% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -63.055% |
| ONE Bio Corp. | 8.67 Million USD | 251.461% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 74.577% |
| Mesoblast Limited | -87.95 Million USD | 85.059% |
| MultiCell Technologies, Inc. | -380.07 USD | -3457606.212% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -252.041% |
| Genscript Biotech Corporation | -95.47 Million USD | 86.236% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1978.045% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -451.971% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -99.84% |
| Biomind Labs Inc. | -1.21 Million USD | -982.228% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -323.684% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -66.286% |
| Skye Bioscience, Inc. | -37.64 Million USD | 65.09% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -574.193% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -20.658% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -87651.763% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -168.963% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -88.2% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 17.199% |
| Accustem Sciences Inc. | -3.74 Million USD | -250.78% |
| EV Biologics, Inc. | -1.26 Million USD | -937.12% |
| Q BioMed Inc. | -2.05 Million USD | -540.405% |
| GB Sciences, Inc. | -1.36 Million USD | -865.112% |
| Alpha Cognition Inc. | -13.77 Million USD | 4.581% |
| CSL Limited | 2.64 Billion USD | 100.497% |
| Agentix Corp. | -1.37 Million USD | -856.309% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 77.996% |
| Enzolytics Inc. | -2.17 Million USD | -503.708% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -3.61 Million USD | -264.036% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -314.377% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -125.909% |
| argenx SE | -295.05 Million USD | 95.546% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 79.007% |
| HST Global, Inc. | -146.21 Thousand USD | -8888.239% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 13509.902% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -648.913% |
| Halberd Corporation | -79.67 Thousand USD | -16393.93% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 289.783% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -334.274% |
| Zenith Capital Corp. | -10.59 Million USD | -24.025% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -230.776% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -216.978% |
| AVAX Technologies, Inc. | -6.41 Million USD | -104.902% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -21643.169% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -555.409% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -56442.914% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -175.554% |
| Helix BioMedix, Inc. | -1.05 Million USD | -1144.412% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -244.114% |
| Kadimastem Ltd | -3.3 Million USD | -297.343% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | -54.918% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -2877.487% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -884.08% |
| LadRx Corporation | 400.44 Thousand USD | 3381.791% |
| Cell Source, Inc. | -5.32 Million USD | -146.968% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -3063.025% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1383.986% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1383.986% |
| Affymax, Inc. | -14.42 Million USD | 8.89% |
| Mobile Lads Corp. | -2.26 Million USD | -480.646% |
| Itoco Inc. | -1.86 Million USD | -603.143% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -195.815% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -687.4% |
| International Stem Cell Corporation | -131 Thousand USD | -9931.835% |
| CytoDyn Inc. | -49.84 Million USD | 73.633% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -16528.122% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -5660.696% |
| Qrons Inc. | -789.34 Thousand USD | -1564.883% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -1295.783% |
| SYBLEU INC | -180.3 Thousand USD | -7188.637% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -529.488% |
| Rebus Holdings, Inc. | -1.02 Million USD | -1188.402% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -714.87% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -24114.519% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -419.384% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 72.662% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -521.651% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -1582.92% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -314.827% |
| Neutra Corp. | -233.46 Thousand USD | -5528.983% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 35.234% |
| PureTech Health plc | -65.69 Million USD | 79.996% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 38.205% |
| IXICO plc | -1.17 Million USD | -1015.595% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -32.383% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 76.996% |
| CSL Limited | 2.64 Billion USD | 100.497% |
| Cellectis S.A. | -103.17 Million USD | 87.263% |